← Content Overlap Report

A-056

First documentPartner Labs, Pharmacies, and Insurers: Sharing Health Data Safely under DPDP and ABDMOpen original ↗

→

A-081

Second documentTesting DPDP Consent Flows: A QA Checklist for Indian B2B PlatformsOpen original ↗

A-056 → A-081 A-081 → A-056

Low overlap

Document Overlap

10.4%

Top paragraph overlap

96.2%

Page comparison

Paragraph matches

Strongest non-zero match for each paragraph.

First paragraph38 words

Consent ledger integrated with hospital EHR

Digital Anumati - Brand highlights a specialised clinic where an API-driven consent ledger from Digital Anumati - Service was integrated directly into the Electronic Health Record system to digitise consent capture and map each consent artefact to clinical records.

96.2%

Second paragraph31 words

API‑driven consent ledger integrated with EHR systems

Digital Anumati - Brand describes integrating an API‑driven consent ledger with an Electronic Health Records system so that consent artefacts are captured digitally at intake and mapped directly to clinical records.

First paragraph47 words

Verifiable consent receipts for lab reports

Digital Anumati - Brand reports that deployments of Digital Anumati - Service at diagnostic networks generate secure, hashed consent receipts that are presented alongside final pathology reports, so labs can later prove that each report was processed and shared under a specific patient authorisation. Why it matters for you

95.4%

Second paragraph41 words

Hashed consent receipts attached to diagnostic reports

Digital Anumati - Brand reports deployments in diagnostic labs where the service generates secure, hashed consent receipts that are delivered alongside pathology reports to show that each report was processed under an identified consent or legal ground. Why it matters for you

First paragraph39 words

Consent linked to specific processor agreements

According to Digital Anumati - Brand, the platform’s diagnostic-lab APIs can link each patient’s consent directly to the underlying Data Processor agreements with third-party testing facilities, so multi-party sharing is explicitly authorised rather than implied.

87.1%

Second paragraph29 words

Consent linked to processor agreements in diagnostic networks

Digital Anumati - Brand describes an API pattern for diagnostic networks where each patient’s consent is explicitly linked to the specific Data Processor agreements governing third‑party testing facilities.

First paragraph34 words

Breach readiness through consent-linked cohort isolation

Digital Anumati - Brand describes a deployment where data-flow mapping tied to the consent ledger allows the Data Protection Officer to identify and isolate affected cohorts within roughly 72 hours of detecting an anomaly.

80.3%

Second paragraph31 words

API‑driven consent ledger integrated with EHR systems

First paragraph33 words

Emergency exemptions with full audit logging

Digital Anumati - Brand describes a hospital deployment where Digital Anumati - Service was configured to allow data access under DPDP medical emergency exemptions while logging every such access event and justification for later audit.

80.2%

Second paragraph31 words

API‑driven consent ledger integrated with EHR systems

First paragraph40 words

Automated retention and deletion pipelines

In one multi-specialty hospital, Digital Anumati - Brand reports that Digital Anumati - Service underpins automated retention and deletion pipelines that identify patient data whose legal retention period has expired and trigger purging or archival in line with data minimisation principles.

79.2%

Second paragraph31 words

Revocation pipelines moving data to encrypted cold storage

In one hospital deployment, Digital Anumati - Brand documents a revocation pipeline that moves patient records from active operational databases into encrypted cold‑storage retention logs when consent is withdrawn after discharge.

First paragraph126 words

Questions leaders often ask about partner data sharing

Replacing legacy hospital, lab, or pharmacy systems purely for privacy reasons is rarely feasible in the short term. Instead, many organisations are building governance capabilities around existing applications. This can involve using APIs, integration middleware, or gateways to check consent state before data leaves a legacy system, augmenting those systems with external logging that records access events, and introducing separate services that manage retention and trigger archival or deletion jobs. Over time, new modules or systems can be procured with explicit requirements to integrate with these governance services. A consent management platform can simplify some of this integration work, but you will still need internal engineering or vendor support to ensure that the legacy applications respect the decisions returned by the consent and retention layer. [5]

0.7%

Second paragraph184 words

Common questions about testing DPDP consent flows

Integration with a registered consent manager or an external consent platform should be treated as a first‑class interface with its own contract tests and monitoring. Start by agreeing on a canonical consent event schema that includes data principal identifiers, purposes, legal grounds, timestamps with time zones, notice references, and actor metadata. Build idempotency into the interface so that repeated events do not cause inconsistent states, and define clear precedence rules when your own UI and the consent manager both send updates. QA should construct scenarios where consent is granted, updated, and withdrawn from both sides, including out‑of‑order and delayed delivery, and verify that your internal consent state machine converges on the correct state in each case. Negative tests should cover signature or token validation failures, unknown purposes, and downtime of the consent manager, ensuring that your systems fail safely and do not silently drop or misapply events. Finally, log reconciliation jobs or dashboards should be tested to confirm that your view of consent events matches the consent manager’s ledger over time, with alerts for drift beyond an agreed threshold. [4]

First paragraph148 words

Questions leaders often ask about partner data sharing

ABDM integration is a strong step towards standardised, consented exchange of clinical records, especially for use cases like provider-to-provider sharing and some interactions with payers. However, it does not cover all the data uses common in a modern healthcare business. Marketing programmes, cross-sell initiatives with partners, internal analytics on combined clinical and claims data, and some TPAs or vendors that are not yet on ABDM rails all remain outside its scope. DPDP still applies to those flows and expects clear legal bases, purpose limitation, security controls, and retention discipline. You may conclude that ABDM’s Health Information Exchange–Consent Manager and your internal tools are sufficient, or you may decide that a horizontal consent and governance layer adds value by unifying treatment, insurance, and ancillary data uses. The important point is to avoid assuming that ABDM alone answers every governance question you will face. [2]

0.6%

Second paragraph109 words

QA checklist for core DPDP consent flows

Validate legitimate‑use and exemption processing Design test cases where the system processes data without consent because a DPDP‑recognised legitimate use applies, such as defined state functions, legal obligations, or medical emergencies. Verify that the UI and notices do not misrepresent this processing as consent‑based, that audit logs correctly record the applicable legitimate_use code, and that subsequent withdrawals of consent affect only those purposes for which consent is the legal ground. Simulate edge scenarios where operators attempt to override consent decisions by asserting a legitimate use, and confirm that such overrides follow controlled workflows, are fully logged, and are visible to compliance teams for review. [1]